LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Expansion Affinia Therapeutics recently expanded its offices to Waltham, Massachusetts, showcasing growth potential and the need for new solutions in the gene therapy market.

Financial Health With a recent financing round of $110 million in Series B funding and revenue ranging from $10M - 50M, Affinia Therapeutics demonstrates strong financial stability and investment attractiveness.

Technology Innovation Affinia Therapeutics is leveraging cutting-edge technology such as AI and structural modeling to develop rationally-designed gene therapies, presenting opportunities for partnerships with tech-savvy healthcare organizations.

Keyperson Appointment The appointment of Rami Daoud as Chief Business and Financial Officer brings expertise in strategic growth initiatives, indicating a focus on expanding market reach and potential collaborations.

Competitive Positioning In a landscape with similar companies like Forge Biologics, Dyno Therapeutics, and more, Affinia Therapeutics stands out with its unique approach to gene therapy delivery, offering differentiation for targeted sales strategies.

Similar companies to Affinia Therapeutics

Affinia Therapeutics Tech Stack

Affinia Therapeutics uses 8 technology products and services including NetSuite, Microsoft Excel, Polyfill, and more. Explore Affinia Therapeutics's tech stack below.

  • NetSuite
    E-commerce
  • Microsoft Excel
    Editors
  • Polyfill
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • Python
    Programming Languages
  • Greenhouse
    Recruitment Marketing
  • Nginx
    Web Servers
  • Apache
    Web Servers

Media & News

Affinia Therapeutics's Email Address Formats

Affinia Therapeutics uses at least 1 format(s):
Affinia Therapeutics Email FormatsExamplePercentage
FLast@affiniatx.comJDoe@affiniatx.com
94%
F-Last@affiniatx.comJ-Doe@affiniatx.com
3%
FMiddleLast@affiniatx.comJMichaelDoe@affiniatx.com
2%
FMLast@affiniatx.comJMDoe@affiniatx.com
1%

Frequently Asked Questions

Where is Affinia Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Affinia Therapeutics's main headquarters is located at 43 Foundry Ste 120 Waltham, Massachusetts 02453 US. The company has employees across 2 continents, including North AmericaEurope.

What is Affinia Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Affinia Therapeutics is a publicly traded company; the company's stock symbol is AFTX.

What is Affinia Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Affinia Therapeutics's official website is affiniatx.com and has social profiles on LinkedIn.

How much revenue does Affinia Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, Affinia Therapeutics's annual revenue reached $15M.

What is Affinia Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Affinia Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Affinia Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, Affinia Therapeutics has approximately 69 employees across 2 continents, including North AmericaEurope. Key team members include Chief Scientific Officer: C. A.Chief Development Officer: L. R.Chief Business And Financial Officer: R. D.. Explore Affinia Therapeutics's employee directory with LeadIQ.

What industry does Affinia Therapeutics belong to?

Minus sign iconPlus sign icon
Affinia Therapeutics operates in the Biotechnology Research industry.

What technology does Affinia Therapeutics use?

Minus sign iconPlus sign icon
Affinia Therapeutics's tech stack includes NetSuiteMicrosoft ExcelPolyfillMicrosoftPythonGreenhouseNginxApache.

What is Affinia Therapeutics's email format?

Minus sign iconPlus sign icon
Affinia Therapeutics's email format typically follows the pattern of . Find more Affinia Therapeutics email formats with LeadIQ.

How much funding has Affinia Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, Affinia Therapeutics has raised $110M in funding. The last funding round occurred on May 03, 2021 for $110M.

When was Affinia Therapeutics founded?

Minus sign iconPlus sign icon
Affinia Therapeutics was founded in 2019.
Affinia Therapeutics

Affinia Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

We are a team with decades of proven success in translating science from bench to bedside across many companies and medicines, in gene therapy and beyond. We are driven by a purpose: to make a lasting positive impact in the lives of people affected by devastating rare and prevalent diseases where the genetic cause is understood.

Our thesis is simple and our vision, clear: gene therapies have an immense potential to cure many diseases with a one-time dose, but they are limited by current delivery methods for the genetic payload. We formed Affinia Therapeutics to singularly focus on creating innovations that can expand the reach of gene therapies to more prevalent diseases. We're re-engineering adeno-associated virus serotype 9 (AAV9), a gene therapy delivery method that has shown promise but only in a small number of diseases. 

At Affinia Therapeutics, we call it ART: Affinia Rationally-designed Therapies. ART can benefit any tissue of interest such as the eye, heart, kidney, liver, lung, muscle, nervous system, or pancreas. We use AI, structural modeling, and other cutting-edge scientific tools to methodically re-design AAV9, enabling it to better target tissues and cells that are the desired sites of efficacy while avoiding sites of toxicity. Our goal is genetic medicines that can be given as a one-time dose to effectively and safely correct defective genes in the body – the underlying root cause of many diseases. We dream of using the word “cure.”

As an early team member you will play a key role in setting our culture and values. You will be working alongside the founding management team who have a track record of success in the industry. The pace of work is dynamic, fast and fun. 

Our site includes:  State of the Art lab space & Equipment-
Healthy Cafe, Outdoor Patio, State of the Art Gym/Yoga Studio, Lounge ( Pool Table/ Golf Simulator ), Free/Plentiful Parking and More!

Join Us! 



Section iconCompany Overview

Headquarters
43 Foundry Ste 120 Waltham, Massachusetts 02453 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
AFTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $110M

    Affinia Therapeutics has raised a total of $110M of funding over 2 rounds. Their latest funding round was raised on May 03, 2021 in the amount of $110M.

  • $10M$50M

    Affinia Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $110M

    Affinia Therapeutics has raised a total of $110M of funding over 2 rounds. Their latest funding round was raised on May 03, 2021 in the amount of $110M.

  • $10M$50M

    Affinia Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.